Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
The HIV Vaccine Trials Network (HVTN) Laboratory Center in the Immunology & Vaccine Development Program of the Vaccine & Infectious Disease Division is dedicated to understanding human immune responses and mechanisms of vaccine-induced immune protection against HIV, SARS-CoV-2 and other infectious diseases, such as malaria, Ebola and tuberculosis.
This position will be with the McElrath HVTN Laboratory in the Immunology & Vaccine Development Program within the Vaccine & Infectious Disease Division at Fred Hutch. The position is for a Senior Project Manager to supervise the HVTN Endpoints Laboratory, a good clinical laboratory practices (GCLP) laboratory performing detailed evaluation of T cell responses to candidate vaccines. The laboratorys focus is on clinical trials of HIV and SARS-CoV-2 vaccines as well as investigations of immune responses to HIV and SARS-CoV-2 (COVID-19) infections. The Sr. Project Manager will lead a technical team, design of experiments and collection of data. They will also assist with implementation of GCLP compliance and train technical staff.
Reporting to the HVTN Laboratory Associate Director, the Sr. Project Manager will coordinate and carry out activities including but not limited to:
Lead immune assays, primarily focused on T cell responses: high-dimensional multiparameter flow cytometry, intracellular cytokine staining, viral inhibition assays, multiplexed cytokine detection assays (MSD/Luminex), and other assays as relevant.
Supervise, mentor, and train a team of research technicians
Oversee analysis of flow data and results
Coordinate with statistical groups and internal and external stakeholders
Participation in both formal and informal sharing of data amongst collaborating researchers
Assist with external progress reports, grant applications and scientific articles
Coordinate establishment of new techniques in the laboratory
Other duties and projects as assigned
Ph.D. or M.D. in immunology or a related field, or equivalent combination of relevant work and post-bachelors education experience (i.e. BA/BS with 10+ years work experience or MA/MS with 5+ years work experience) required.
Experience with human immunology and multiparameter flow cytometry and analysis is required
Excellent communication (oral and written) and problem-solving skills are required
Duties will require working in a team-oriented research environment and in serving in a collaborative and supervisory capacity. A strong background in collaborative team leadership, positive communication and project completion is preferred.
Motivation and adaptability are essential, as is a keen interest in the HIV vaccine field
Knowledge of human clinical trials and/or GCLP/GLP experience is required
Proficiency in the following computer programs is necessary: MS Office, Illustrator or other drawing program, Prism, JMP, Excel, R and/or SAS statistical analysis program, and FlowJo and/or other flow data analysis programs
Special qualifications: willingness to work with biohazardous (e.g., HIV-1) materials, required
Hours: Must be flexible, able to work some nights and weekends
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and anti-racism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at firstname.lastname@example.org or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.